LYMPHANGITIC CARCINOMATOSIS
Tracking # 20-1063632
$99999.00
There are no ratings for this course
Learn more Educator STATPEARLS PUBLISHING, LLC
CE Broker Reporting Reported automatically
Method Computer-Based Training
Course overview
LYMPHANGITIC CARCINOMATOSIS IS THE INFILTRATION AND INFLAMMATION OF LYMPHATIC VESSELS SECONDARY TO THE SPREAD OF MALIGNANCY FROM A PRIMARY SITE. PULMONARY LYMPHANGITIC CARCINOMATOSIS ALMOST ALWAYS REPRESENTS THE CLINICAL FORM OF LYMPHANGITIC CARCINOMATOSIS AND DENOTES AN END-STAGE MALIGNANCY WITH POOR PROGNOSIS. THIS ACTIVITY COVERS THE ETIOLOGY, CLINICAL FEATURES, DIAGNOSTIC EVALUATION AND MANAGEMENT OF SUSPECTED PULMONARY LYMPHANGITIC CARCINOMATOSIS AND HIGHLIGHTS THE ROLE OF THE INTERPROFESSIONAL TEAM IN DELIVERING THE BEST OUTCOME IN A GIVEN PATIENT.
Subject areas
This course counts toward the state boards and subject areas below.
Bahamas Medical Council
Specialty Medical Practitioner
1.5h
General Medicine
Louisiana State Board of Medical Examiners - Physicians & Surgeons
Physician & Surgeon
1.5h
Category I CME
Mississippi State Board of Medical Licensure
Medical Doctor
1.5h
AMA Category I
Physician Assistant
1.5h
AMA Category I
State Medical Board of Ohio
Doctor of Medicine
1.5h
AMA Category I